# Bath & Body Works share price today (Bath & Body Works, Inc., BBWI)

> Bath & Body Works, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. BBWI · Consumer Discretionary · Specialty Retail · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/bbwi

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from fewer quarters than usual
- Price: $23.54 (+2.7% in a year)
- P/E: 6.1× (lower than 85% of the last 4.5 years)
- Revenue (Aug 2026): $1.5 B (−2.3% on a year ago)
- Profit (Aug 2026): $118 M (+84.4% on a year ago)
- Operating margin: 9.6% (−1.5 points on a year ago)
- ROE: −51%, FY26
- ROIC: 24.5%, against a 8.1% cost of capital: +16.4 points

The main question: the P/E is near the low end of its own history, higher than only 15% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the Bath & Body Works share price today? Bath & Body Works, Inc.'s share price was $23.54 at the close on 4 November 2026. It has been stalling near its high for 4 weeks. That is 18.8% above its average price over the last 200 trading days. In the last 52 weeks it traded between $15 and $24, and at that close it sat 91% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row. Over the last 10 years the share price moved −66% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Bath & Body Works pay? Bath & Body Works, Inc. paid $0.80 per share over the last four reported quarters. The most recent declaration was $0.20 for Aug 2026. At today's price of $23.54 that is a yield of 3.40%, based on dividends already paid, not a forecast. ## Which stock lists is Bath & Body Works on? Bath & Body Works is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Bath & Body Works profitable? Bath & Body Works, Inc. earned $118 M of net profit in the Aug 2026 quarter, +84.4% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was $649 M. Over 4 years profit has grown −16.5% a year on average. That is 7.8% of the quarter's revenue. The same quarter a year earlier earned $64.0 M. For the full year, FY26 profit was $649 M (−18.7% on the year before). Why profit moved: revenue changed −2.3% on a year earlier and the margin moved −1.5 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +30.1% and revenue −2.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Bath & Body Works make, and is it growing? Bath & Body Works, Inc. reported $1.5 B of revenue in the Aug 2026 quarter, −2.3% on the same quarter a year earlier. Over 4 years it has grown −1.9% a year on average. The last full year, FY26, came in at $7.3 B. The last four reported quarters add to $7.2 B. FY26 revenue was $7.3 B, −0.2% on the year before. Recent pace: the last four quarters grew −2.2% on average, against −1.9% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −2.2%, against −1.2% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +7.3%, against −8.7% a year (accelerating). ## How much of every $100 of sales does Bath & Body Works keep? Bath & Body Works, Inc.'s operating margin was 9.6% in the Aug 2026 quarter, 1.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 15.9% and 25.5%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −1.5 percentage points on the year while gross margin changed −0.9 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Bath & Body Works' profit turning into cash? Over the last 3 years, 127% of Bath & Body Works, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in $1.1 B of operating cash against $649 M of profit. After $237 M of spending on assets, $865 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Bath & Body Works' cash go? Bath & Body Works, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $761 M on assets over the last 3 years. Averaged over those years that is 3.5% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $761 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Bath & Body Works' P/E ratio, and how does it compare with its own history? Bath & Body Works, Inc.'s P/E is 6.1×, near the low end of its own history: it has been lower only 15% of the time. Its usual P/E (the middle reading) is 8.9×, over 4.5 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −13.9% while the price moved +2.7%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved −10.3% a year; about +31.2% a year came from earnings growth and about −41.5 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Bath & Body Works business getting better or worse? Bath & Body Works, Inc.'s business is giving mixed signals. There is no clear direction across the growth lines; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. The return-on-capital line is not shown: net worth is negative, so a return on capital means nothing. The balance sheet is in distress, and this reading uses the growth lines alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Bath & Body Works earn on its capital? Bath & Body Works, Inc. earned a ROE of −51% in FY26. That is up from a low of −88% in FY22. Its return on capital used (ROIC) is 16.4 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 8.9% net margin and 1.44× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 8.9% net margin × 1.44× asset turnover × −3.96× leverage (assets divided by equity) ≈ −50.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 24.5% − 8.1% = +16.4 percentage points. The 8.1% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Bath & Body Works have too much debt? Bath & Body Works, Inc.'s net worth is negative: it owes more than it owns, so a debt-to-equity ratio means nothing here. Year by year, that ratio went from −3.96 in FY22 to −3.87 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Bath & Body Works shareholding pattern? 8.7% of Bath & Body Works, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Bath & Body Works from balance-sheet trouble? For Bath & Body Works, Inc., the Z-score is 2.27. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.27 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Bath & Body Works rank in its industry? 61.0 out of 100, rank 4 of 28 in Specialty Retail, with 85% of the evidence available. Bath & Body Works, Inc. scores 61.0 out of 100 against the 28 companies it is compared with in Specialty Retail, ranking 4. Relative strength against the index is 10.2%, and revenue and profit growth are weak. The four parts add up to the total exactly: 10.4 + 18.9 + 15.9 + 15.8 = 61. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Bath & Body Works compared with? Bath & Body Works ranks 4 of 28 Specialty Retail companies on the 4-Factor Sector Score, with 61.0 out of 100. 1. [Five Below, Inc.](https://www.sectoralpha.in/us/stocks/five) FIVE · losing its lead · Most evidence points up · 85% evidence 73.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.1/35 · Revenue 25.5% · Profit 100% · Operating margin change 3.8 points · 95% evidence Capital efficiency 15.1/25 · ROCE 14.5% · Operating margin 8.9% · 76% evidence Valuation 13.5/20 · P/E 19.4× · PEG 0.72 · 65% evidence Relative strength 12.4/20 · Lead over its industry 5.9% · Lead over S&P 500 11.9% · 1 year 65.5% · 100% evidence · 10 of 12 weeks ahead Exact sum: 32.1 + 15.1 + 13.5 + 12.4 = 73.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Best Buy Co., Inc.](https://www.sectoralpha.in/us/stocks/bby) BBY · leader · Most evidence points up · 85% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.0/35 · Revenue 1.4% · Profit 63.5% · Operating margin change 0 points · 95% evidence Capital efficiency 17.2/25 · ROCE 25.4% · Operating margin 3.9% · 76% evidence Valuation 15.6/20 · P/E 14.3× · PEG 0.35 · 65% evidence Relative strength 17.6/20 · Lead over its industry 19.3% · Lead over S&P 500 26.3% · 1 year 28.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 20 + 17.2 + 15.6 + 17.6 = 70.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Academy Sports and Outdoors, Inc.](https://www.sectoralpha.in/us/stocks/aso) ASO · breaking out · Most evidence points up · 85% evidence 69.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.8/35 · Revenue 3.7% · Profit 7% · Operating margin change 4.2 points · 95% evidence Capital efficiency 15.2/25 · ROCE 13.3% · Operating margin 15% · 76% evidence Valuation 14.9/20 · P/E 7.4× · PEG 0.6 · 65% evidence Relative strength 17.6/20 · Lead over its industry 13.9% · Lead over S&P 500 19.8% · 1 year 47.9% · 100% evidence · 6 of 12 weeks ahead Exact sum: 21.8 + 15.2 + 14.9 + 17.6 = 69.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. Bath & Body Works, Inc. this page BBWI · turning · Evidence leans up · 85% evidence 61.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.4/35 · Revenue -2.2% · Profit 7.3% · Operating margin change -1.5 points · 95% evidence Capital efficiency 18.9/25 · ROCE 31.1% · Operating margin 9.6% · 76% evidence Valuation 15.9/20 · P/E 5.2× · PEG 0.36 · 65% evidence Relative strength 15.8/20 · Lead over its industry 5% · Lead over S&P 500 10.2% · 1 year 2.7% · 100% evidence · 4 of 12 weeks ahead Exact sum: 10.4 + 18.9 + 15.9 + 15.8 = 61 · What this means: Relative strength against the index is 10.2%, and revenue and profit growth are weak. 5. [Murphy USA Inc.](https://www.sectoralpha.in/us/stocks/musa) MUSA · quiet · Evidence leans up · 81% evidence 60.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.0/35 · Revenue 11.3% · Profit 25.7% · Operating margin change -0.1 points · 83% evidence Capital efficiency 16.8/25 · ROCE 23.5% · Operating margin 4.9% · 76% evidence Valuation 14.8/20 · P/E 16.1× · PEG 0.45 · 65% evidence Relative strength 5.0/20 · Lead over its industry -9.8% · Lead over S&P 500 -4.4% · 1 year 38.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24 + 16.8 + 14.8 + 5 = 60.6 · What this means: Earnings are strong; relative strength in its sector is -9.8% and the one-year return is 38.1%. 6. [GameStop Corp.](https://www.sectoralpha.in/us/stocks/gme) GME · breaking out · Evidence leans up · 75% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue -7.7% · Profit 100% · Operating margin change 13.4 points · 95% evidence Capital efficiency 9.6/25 · ROCE 4.7% · Operating margin 20% · 76% evidence Valuation 10.7/20 · P/E 10.9× · PEG n/a · 15% evidence Relative strength 12.9/20 · Lead over its industry -0.8% · Lead over S&P 500 4.6% · 1 year 16.9% · 100% evidence · 5 of 12 weeks ahead Exact sum: 23.7 + 9.6 + 10.7 + 12.9 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Ulta Beauty, Inc.](https://www.sectoralpha.in/us/stocks/ulta) ULTA · breaking out · Evidence leans up · 85% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.7/35 · Revenue 11.2% · Profit 0.8% · Operating margin change 0.1 points · 95% evidence Capital efficiency 19.7/25 · ROCE 34.5% · Operating margin 12.5% · 76% evidence Valuation 5.7/20 · P/E 18.2× · PEG 3.52 · 65% evidence Relative strength 14.5/20 · Lead over its industry 4.7% · Lead over S&P 500 9.9% · 1 year 27.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 16.7 + 19.7 + 5.7 + 14.5 = 56.6 · What this means: Relative strength against the index is 9.9%, and revenue and profit growth are weak. 8. [Sally Beauty Holdings, Inc.](https://www.sectoralpha.in/us/stocks/sbh) SBH · leader · Evidence leans up · 81% evidence 55.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 1.1% · Profit -0.5% · Operating margin change 0.8 points · 83% evidence Capital efficiency 13.6/25 · ROCE 12.5% · Operating margin 9.3% · 76% evidence Valuation 11.9/20 · P/E 7× · PEG 1.28 · 65% evidence Relative strength 15.6/20 · Lead over its industry 12.8% · Lead over S&P 500 18.9% · 1 year 37.3% · 100% evidence · 11 of 12 weeks ahead Exact sum: 14.2 + 13.6 + 11.9 + 15.6 = 55.3 · What this means: Relative strength against the index is 18.9%, and revenue and profit growth are weak. 9. [Williams-Sonoma, Inc.](https://www.sectoralpha.in/us/stocks/wsm) WSM · breaking out · Evidence leans up · 85% evidence 54.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Revenue 2.2% · Profit 4.6% · Operating margin change -0.6 points · 95% evidence Capital efficiency 20.7/25 · ROCE 39.6% · Operating margin 17.3% · 76% evidence Valuation 6.6/20 · P/E 22.8× · PEG 2.67 · 65% evidence Relative strength 14.4/20 · Lead over its industry 14.1% · Lead over S&P 500 20.5% · 1 year 37% · 100% evidence · 8 of 12 weeks ahead Exact sum: 13.2 + 20.7 + 6.6 + 14.4 = 54.9 · What this means: Relative strength against the index is 20.5%, and revenue and profit growth are weak. 10. [Casey's General Stores, Inc.](https://www.sectoralpha.in/us/stocks/casy) CASY · quiet · Evidence leans up · 85% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.2/35 · Revenue 13.8% · Profit 33% · Operating margin change -0.2 points · 95% evidence Capital efficiency 14.0/25 · ROCE 14.3% · Operating margin 6.5% · 76% evidence Valuation 10.2/20 · P/E 41.7× · PEG 1.25 · 65% evidence Relative strength 3.4/20 · Lead over its industry -15.2% · Lead over S&P 500 -10.4% · 1 year 26.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.2 + 14 + 10.2 + 3.4 = 52.8 · What this means: Earnings are strong; relative strength in its sector is -15.2% and the one-year return is 26.5%. 11. [Arhaus, Inc.](https://www.sectoralpha.in/us/stocks/arhs) ARHS · leader · Evidence leans up · 81% evidence 52.6 out of 100 Growth Capital Valuation Relative
12. [Barnes & Noble Education, Inc.](https://www.sectoralpha.in/us/stocks/bned) BNED · turning · Evidence leans up · 67% evidence 52.0 out of 100 Growth Capital Valuation Relative
13. [MarineMax, Inc.](https://www.sectoralpha.in/us/stocks/hzo) HZO · leader · Evidence leans down · 64% evidence 49.8 out of 100 Growth Capital Valuation Relative
14. [ChargePoint Holdings, Inc.](https://www.sectoralpha.in/us/stocks/chpt) CHPT · breaking out · Evidence leans down · 64% evidence 49.1 out of 100 Growth Capital Valuation Relative
15. [Winmark Corporation](https://www.sectoralpha.in/us/stocks/wina) WINA · basing · Evidence leans down · 85% evidence 45.4 out of 100 Growth Capital Valuation Relative
16. [Petco Health and Wellness Company, Inc.](https://www.sectoralpha.in/us/stocks/woof) WOOF · turning · Evidence leans down · 67% evidence 43.8 out of 100 Growth Capital Valuation Relative
17. [Savers Value Village, Inc.](https://www.sectoralpha.in/us/stocks/svv) SVV · quiet · Too little evidence to rank firmly · 58% evidence 43.2 out of 100 Growth Capital Valuation Relative
18. [Build-A-Bear Workshop, Inc.](https://www.sectoralpha.in/us/stocks/bbw) BBW · basing · Evidence leans down · 85% evidence 42.9 out of 100 Growth Capital Valuation Relative
19. [EVgo, Inc.](https://www.sectoralpha.in/us/stocks/evgo) EVGO · turning · Evidence leans down · 64% evidence 42.1 out of 100 Growth Capital Valuation Relative
20. [National Vision Holdings, Inc.](https://www.sectoralpha.in/us/stocks/eye) EYE · quiet · Too little evidence to rank firmly · 58% evidence 41.2 out of 100 Growth Capital Valuation Relative
21. [Tractor Supply Company](https://www.sectoralpha.in/us/stocks/tsco) TSCO · breaking out · Evidence leans down · 85% evidence 37.2 out of 100 Growth Capital Valuation Relative
22. [RH](https://www.sectoralpha.in/us/stocks/rh) RH · basing · Evidence leans down · 85% evidence 35.5 out of 100 Growth Capital Valuation Relative
23. [DICK'S Sporting Goods, Inc.](https://www.sectoralpha.in/us/stocks/dks) DKS · basing · Most evidence points down · 85% evidence 31.5 out of 100 Growth Capital Valuation Relative
24. [Arko Corp.](https://www.sectoralpha.in/us/stocks/arko) ARKO · basing · Most evidence points down · 81% evidence 26.9 out of 100 Growth Capital Valuation Relative
25. 1-800-FLOWERS.COM, Inc. FLWS · quiet · Most evidence points down · 64% evidence 25.4 out of 100 Growth Capital Valuation Relative
26. [Bob's Discount Furniture, Inc.](https://www.sectoralpha.in/us/stocks/bobs) BOBS · turning · Too little evidence to rank firmly · 36% evidence 61.9 out of 100 Growth Capital Valuation Relative
27. [Olaplex Holdings, Inc.](https://www.sectoralpha.in/us/stocks/olpx) OLPX · Too little evidence to rank firmly · 31% evidence 39.9 out of 100 Growth Capital Valuation Relative
28. [Bed Bath & Beyond, Inc.](https://www.sectoralpha.in/us/stocks/bbby) BBBY · Too little evidence to rank firmly · 31% evidence 38.8 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Retail](https://www.sectoralpha.in/us/sectors/specialty-retail), all 28 compared on one page. ## Which companies are close to Bath & Body Works in size? Bath & Body Works is the 10th largest of 29 Specialty Retail companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: DICK'S Sporting Goods, Inc., GameStop Corp. and Murphy USA Inc. Just below it: Academy Sports and Outdoors, Inc., MINISO Group Holding and RH. ### Specialty Retail companies close in size

1. [DICK'S Sporting Goods, Inc.](https://www.sectoralpha.in/us/stocks/dks) $13.1 billion
2. [GameStop Corp.](https://www.sectoralpha.in/us/stocks/gme) $12.7 billion
3. [Murphy USA Inc.](https://www.sectoralpha.in/us/stocks/musa) $9.1 billion
4. Bath & Body Works, Inc. $4.7 billion
5. [Academy Sports and Outdoors, Inc.](https://www.sectoralpha.in/us/stocks/aso) $4.2 billion
6. [MINISO Group Holding Limited](https://www.sectoralpha.in/us/stocks/mnso) $3.1 billion
7. [RH](https://www.sectoralpha.in/us/stocks/rh) $2.7 billion

[All 29 Specialty Retail companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-retail#all-companies)

### Companies close in size in other industries

1. [Laureate Education, Inc.](https://www.sectoralpha.in/us/stocks/laur) $4.8 billion · Education & Training Services
2. [UFP Industries, Inc.](https://www.sectoralpha.in/us/stocks/ufpi) $4.8 billion · Lumber & Wood Production
3. Bath & Body Works, Inc. $4.7 billion
4. [Option Care Health, Inc.](https://www.sectoralpha.in/us/stocks/opch) $4.7 billion · Medical Care Facilities
5. [Camtek Ltd.](https://www.sectoralpha.in/us/stocks/camt) $4.7 billion · Semiconductor Equipment & Materials

## What else do people ask about Bath & Body Works? ### What were Bath & Body Works's latest quarterly results? Bath & Body Works, Inc. reported revenue of $1.5 B and net profit of $118 M for the Aug 2026 quarter. Revenue fell 2.3% and profit rose 84.4% compared with a year earlier. Earnings per share were $0.58 (as of 4 November 2026). ### What is Bath & Body Works's market cap? Bath & Body Works, Inc.'s market capitalisation is $4.7 B at a stock price of $23.54. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Bath & Body Works performing? Bath & Body Works, Inc.'s share price has been stalling near its high for 4 weeks. In its latest quarter, revenue fell 2.3% and profit rose 84.4% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running (as of 4 November 2026). ### Will Bath & Body Works's stock price go up? This page does not forecast Bath & Body Works, Inc.'s stock price. What it shows instead: the stock price is $23.54, and it has been stalling near its high for 4 weeks. Its P/E of 6.1× is higher than 15% of its own last 5 years (as of 4 November 2026). ### Where is Bath & Body Works in its business cycle? Bath & Body Works, Inc.'s FY26 operating margin was 15.9%, against a 5-year range of 15.9% to 25.5%: the low end of its own range, which is often where recoveries start. The latest quarter was 9.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Bath & Body Works story? The main question: the P/E is near the low end of its own history, higher than only 15% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Bath & Body Works a stock worth studying right now? What the numbers show: Bath & Body Works, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.